Plasmodium Sporozoite NPDP Peptides Malaria Vaccine EP3612562A2
Summary
The European Patent Office published patent application EP3612562A2, filed by Institute for Research in Biomedicine, Schweizerisches Tropen- und Public Health-Institut, and Seattle Children's Hospital d/b/a Seattle Children's Research Institute. The patent covers NPDP peptides derived from Plasmodium sporozoites for use as malaria vaccines and as targets for antibody binding. The designated states include all EU member states plus various European Economic Area countries, providing patent protection across a broad geographic scope.
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.
What changed
The EPO published patent application EP3612562A2, a granted A2 patent covering NPDP peptides derived from Plasmodium sporozoites and their applications in malaria vaccination and antibody development. The applicants are Institute for Research in Biomedicine, Schweizerisches Tropen- und Public Health-Institut, and Seattle Children's Hospital d/b/a Seattle Children's Research Institute. Inventors include Antonio Lanzavecchia, Joshua Hoong Yu Tan, Claudia Daubenberger, and Brandon Sack.
Affected parties include research institutions and pharmaceutical companies active in malaria vaccine development, who should review this patent landscape to identify potential licensing opportunities or design-around strategies for competing vaccine candidates.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PLASMODIUM SPOROZOITE NPDP PEPTIDES AS VACCINE AND TARGET NOVEL MALARIA VACCINES AND ANTIBODIES BINDING TO
Publication EP3612562A2 Kind: A2 Apr 15, 2026
Applicants
Institute for Research in Biomedicine, Schweizerisches Tropen- und Public Health-Institut, Seattle Children's Hospital d/b/a Seattle
Children's Research Institute
Inventors
LANZAVECCHIA, Antonio, TAN, Joshua Hoong Yu, DAUBENBERGER, Claudia, SACK, Brandon
IPC Classifications
C07K 16/20 20060101AFI20191024BHEP A61K 38/03 20060101ALI20191024BHEP A61K 39/015 20060101ALI20191024BHEP A61P 33/06 20060101ALI20191024BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.